India Forms High-Level Panel Amid West Asia Crisis; Pharma Sector Welcomes Relief Measures

New Delhi, April 3: The ongoing conflict in West Asia has escalated into a global economic concern, disrupting international supply chains and significantly increasing freight costs, thereby affecting the availability of critical energy products such as LPG and petrochemicals. In response to the evolving situation, the Government of India has constituted a high-level committee to closely monitor developments and coordinate necessary interventions to mitigate the impact on domestic industries and consumers. The ripple effects of the crisis have been felt across multiple sectors, with logistics challenges and rising transportation costs posing a serious threat to supply stability. Key industries reliant on imported raw materials, especially energy-linked inputs, are facing mounting pressure. Amid these challenges, the pharmaceutical sector has expressed support for the government's proactive measures. Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance, welcomed recent policy steps including duty exemptions and freight support. “These measures are crucial in ensuring that the supply of essential medicines remains uninterrupted for patients across the country,” Jain stated, emphasizing the importance of maintaining stability in the healthcare supply chain during global disruptions. The government’s interventions are expected to provide relief to manufacturers and exporters, ensuring that India’s pharmaceutical sector—one of the largest globally—continues to function smoothly despite external shocks. Officials indicated that the situation is being reviewed on a continuous basis, with further measures likely if global conditions worsen